Experimental Study of Almonertinib Crossing the Blood-Brain Barrier in EGFR-Mutant NSCLC Brain Metastasis and Spinal Cord Metastasis Models

Roughly one third of non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)-sensitive mutated (EGFRm) tumors experience disease progression through central nervous system (CNS) metastases during treatment. Although EGFR-TKIs have been r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuhan, Zhang, Yaoshuai, Niu, Wenwen, Ge, Xianming, Huang, Fuhao, Pang, Jinlong, Li, Xian, Wang, Yu, Gao, Wei, Fan, Fangtian, Li, Shanshan, Liu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497791/
https://www.ncbi.nlm.nih.gov/pubmed/34630120
http://dx.doi.org/10.3389/fphar.2021.750031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497791/
https://www.ncbi.nlm.nih.gov/pubmed/34630120
http://dx.doi.org/10.3389/fphar.2021.750031

Ejemplares similares